| ASSET | QUARTER | % RETURN |
|---|---|---|
NetEase (NTES) | Q3 2002 | 126.38% |
Sarepta Therapeutics (SRPT) | Q3 2002 | 63.78% |
Ferguson (FERG) | Q3 2002 | 49.94% |
MicroStrategy (MSTR) | Q3 2002 | 45.18% |
Western Digital (WDC) | Q3 2002 | 43.29% |
Neurocrine Biosciences (NBIX) | Q3 2002 | 43.16% |
XPO Logistics (XPO) | Q3 2002 | 41.34% |
Take-Two Interactive Software (TTWO) | Q3 2002 | 40.78% |
United Therapeutics (UTHR) | Q3 2002 | 38.24% |
STERIS (STE) | Q3 2002 | 30.01% |
Old Dominion Freight Line (ODFL) | Q3 2002 | 22.74% |
Enterprise Products Partners (EPD) | Q3 2002 | 22.21% |
Biogen (BIIB) | Q3 2002 | 22.08% |
Ball (BALL) | Q3 2002 | 21.71% |
Omnicom (OMC) | Q3 2002 | 21.18% |
IDEXX Laboratories (IDXX) | Q3 2002 | 19.81% |
Bio-Techne (TECH) | Q3 2002 | 15.86% |
Bunge (BG) | Q3 2002 | 15.2% |
BHP (BHP) | Q3 2002 | 13.92% |
Gold Fields Ltd ADR (GFI) | Q3 2002 | 13.34% |
Carnival Plc ADS (CUK) | Q3 2002 | 13.17% |
Vertex Pharmaceuticals (VRTX) | Q3 2002 | 12.06% |
Cooper Companies, Inc Common Stock (COO) | Q3 2002 | 11.94% |
Biomarin Pharmaceutical (BMRN) | Q3 2002 | 11.35% |
Edwards Lifesciences (EW) | Q3 2002 | 10.54% |
Large-cap stocks are treated as having a market cap of $10B+.
